QQ客服 官方微博 反馈留言

	A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)
	Hu, Xingsheng; Han, Baohui; Gu, Aiqin; Zhang, Yiping; Jiao, Shun Chang; Wang, Chang-li; He, Jintao; Jia, Xueke; Zhang, Li; Peng, Jiewen
	2014
卷号	86期号:2页码:207-212
关键词	Non-small-cell lung cancer Icotinib EGFR TKIs Phase IV real-world study safety efficacy
ISSN号	0169-5002
DOI	10.1016/j.lungcan.2014.08.014
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6685234
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Hu, Xingsheng,Han, Baohui,Gu, Aiqin,et al. A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)[J],2014,86(2):207-212.
APA	Hu, Xingsheng.,Han, Baohui.,Gu, Aiqin.,Zhang, Yiping.,Jiao, Shun Chang.,...&Sun, Yan.(2014).A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).,86(2),207-212.
MLA	Hu, Xingsheng,et al."A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)".86.2(2014):207-212.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。